Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
6.29
+0.93 (17.35%)
At close: Nov 28, 2025, 1:00 PM EST
6.22
-0.07 (-1.14%)
After-hours: Nov 28, 2025, 4:23 PM EST
Savara Market Cap
Savara has a market cap or net worth of $1.52 billion as of November 28, 2025. Its market cap has increased by 130.93% in one year.
Market Cap
1.52B
Enterprise Value
1.42B
1-Year Change
130.93%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.52B, an increase of 1,043.87%. That is a compound annual growth rate of 32.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.28B | 142.89% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |